# INDV (Indivior Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Indivior Pharmaceuticals, Inc. reported $1.37B in revenue and net income of $450.0M for the trailing twelve months ended September 30, 2026 (up 13.4% year over year), with a 85.0% gross margin and a 40.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/INDV
- Markdown: https://convexityos.com/fundamentals/INDV.md
- SEC CIK: 0001625297
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:17 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001625297&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.37B | +13.4% YoY |
| Operating Income | TTM | $558.0M | 40.6% margin |
| Net Income | TTM | $450.0M | 32.8% net margin |
| Diluted EPS | TTM | $3.69 | Split-adjusted |
| Free Cash Flow | TTM | $31.00M | 2.3% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $305.0M | Total debt: $501.0M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.24B | $1.19B | $1.09B | $901.0M | $791.0M |
| Cost of Revenue | $246.0M | $231.0M | $174.0M | $151.0M | $127.0M |
| **Gross Profit** | $994.0M | $957.0M | $919.0M | $749.0M | $664.0M |
| Research & Development | $97.00M | $107.0M | $116.0M | $74.00M | $52.00M |
| Selling, General & Admin | $634.0M | $612.0M | $565.0M | $466.0M | $431.0M |
| Total Operating Expenses | -- | $919.0M | $1.07B | $827.0M | -- |
| **Operating Income** | $262.0M | $38.00M | -$152.0M | -$77.00M | $213.0M |
| **EBITDA** | $272.0M | $54.00M | -$137.0M | -$61.00M | $228.0M |
| Interest Income | $22.00M | $23.00M | $43.00M | $19.00M | $4.00M |
| Interest Expense | $45.00M | $41.00M | $35.00M | $27.00M | $27.00M |
| Income Before Tax | $239.0M | $20.00M | -$145.0M | -$86.00M | $190.0M |
| Income Tax Expense | $29.00M | $13.00M | -$19.00M | -$43.00M | -$15.00M |
| **Net Income** | $210.0M | $7.00M | -$126.0M | -$42.00M | $205.0M |
| Basic EPS | $1.68 | $0.05 | -$0.92 | -$0.30 | $7.05 |
| **Diluted EPS** | $1.64 | $0.05 | -$0.92 | -$0.30 | $6.75 |
| Basic Shares Outstanding | 125.0M | 132.0M | 137.0M | 139.0M | 29.1M |
| Diluted Shares Outstanding | 128.0M | 133.0M | 137.0M | 139.0M | 30.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $356.0M | $343.0M | $317.0M | $358.0M | $314.0M | $302.0M | $266.0M | $299.0M |
| Cost of Revenue | $51.00M | $50.00M | $40.00M | $67.00M | $83.00M | $52.00M | $44.00M | $48.00M |
| **Gross Profit** | $305.0M | $294.0M | $277.0M | $292.0M | $230.0M | $250.0M | $221.0M | $250.0M |
| Research & Development | $5.00M | $12.00M | $16.00M | $21.00M | $33.00M | $21.00M | $22.00M | $31.00M |
| Selling, General & Admin | $119.0M | $122.0M | $124.0M | $189.0M | $154.0M | $158.0M | $133.0M | $175.0M |
| Total Operating Expenses | $125.0M | $134.0M | $139.0M | -- | $187.0M | $179.0M | $156.0M | $205.0M |
| **Operating Income** | $180.0M | $160.0M | $137.0M | $81.00M | $43.00M | $72.00M | $66.00M | $46.00M |
| **EBITDA** | $181.0M | $162.0M | $139.0M | $83.00M | $46.00M | $74.00M | $69.00M | $51.00M |
| Interest Income | $4.00M | $3.00M | $3.00M | $6.00M | $6.00M | $6.00M | $4.00M | $5.00M |
| Interest Expense | $2.00M | $2.00M | $7.00M | $6.00M | $12.00M | $15.00M | $12.00M | $13.00M |
| Income Before Tax | $182.0M | $160.0M | $115.0M | $81.00M | $37.00M | $62.00M | $59.00M | $38.00M |
| Income Tax Expense | $45.00M | $38.00M | $26.00M | -$21.00M | -$5.00M | $44.00M | $11.00M | $17.00M |
| **Net Income** | $137.0M | $122.0M | $89.00M | $102.0M | $42.00M | $18.00M | $47.00M | $21.00M |
| Basic EPS | $1.16 | $1.02 | $0.71 | -- | $0.34 | $0.15 | $0.38 | -- |
| **Diluted EPS** | $1.12 | $0.98 | $0.69 | -- | $0.33 | $0.14 | $0.38 | -- |
| Basic Shares Outstanding | 118.0M | 119.0M | 124.0M | -- | 125.0M | 125.0M | 124.0M | -- |
| Diluted Shares Outstanding | 122.0M | 124.0M | 129.0M | -- | 129.0M | 126.0M | 125.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $195.0M | $319.0M | $316.0M | $774.0M | $1.10B |
| Short-Term Investments | $0 | $1.00M | $94.00M | -- | -- |
| **Cash & Short-Term Investments** | $195.0M | $320.0M | $410.0M | $774.0M | $1.10B |
| Accounts Receivable, Net | $253.0M | $254.0M | $254.0M | $220.0M | $202.0M |
| Inventory | $153.0M | $167.0M | $126.0M | $114.0M | $95.00M |
| Other Current Assets | $16.00M | $21.00M | $457.0M | $27.00M | $32.00M |
| **Total Current Assets** | $652.0M | $827.0M | $1.26B | $1.26B | $1.44B |
| Property, Plant & Equipment, Net | $144.0M | $100.0M | $84.00M | $54.00M | $58.00M |
| Goodwill | $2.00M | $2.00M | $5.00M | -- | -- |
| Long-Term Investments | $28.00M | $27.00M | $41.00M | -- | -- |
| Other Non-Current Assets | $27.00M | $39.00M | $36.00M | $38.00M | $106.0M |
| **Total Non-Current Assets** | $549.0M | $489.0M | $691.0M | $510.0M | $388.0M |
| **Total Assets** | $1.20B | $1.32B | $1.76B | $1.77B | $1.83B |
| Accounts Payable | $48.00M | $63.00M | $39.00M | $33.00M | $26.00M |
| Short-Term Debt | $29.00M | $18.00M | $3.00M | $3.00M | $3.00M |
| Other Current Liabilities | $0 | $11.00M | $40.00M | $79.00M | $61.00M |
| **Total Current Liabilities** | $914.0M | $924.0M | $1.28B | $1.02B | $804.0M |
| Long-Term Debt | $290.0M | $315.0M | $237.0M | $237.0M | $239.0M |
| Other Non-Current Liabilities | $21.00M | $18.00M | $31.00M | $428.0M | $474.0M |
| **Total Non-Current Liabilities** | $386.0M | $728.0M | $649.0M | $699.0M | $825.0M |
| **Total Liabilities** | $1.30B | $1.65B | $1.94B | $1.72B | $1.63B |
| **Total Debt (incl. Leases)** | $351.0M | $375.0M | $354.0M | $361.0M | $360.0M |
| Common Stock | $62.00M | $62.00M | $68.00M | $68.00M | $70.00M |
| Retained Earnings | -$243.0M | -$443.0M | -$288.0M | $1.30B | $1.44B |
| Accumulated Other Comp. Income | -$30.00M | -$36.00M | -$30.00M | -$1.29B | -$1.29B |
| **Total Stockholders' Equity** | -$98.00M | -$337.0M | -$184.0M | -$15.00M | $121.0M |
| Total Equity | -$98.00M | -$337.0M | -$184.0M | -$15.00M | $121.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $305.0M | $222.0M | $175.0M | $195.0M | $445.0M | $510.0M | $372.0M | $319.0M |
| Short-Term Investments | -- | -- | -- | $0 | $0 | $0 | $1.00M | $1.00M |
| **Cash & Short-Term Investments** | $305.0M | $222.0M | $175.0M | $195.0M | $445.0M | $510.0M | $373.0M | $320.0M |
| Accounts Receivable, Net | $273.0M | $271.0M | $273.0M | $253.0M | $259.0M | $240.0M | $243.0M | $254.0M |
| Inventory | $149.0M | $150.0M | $152.0M | $153.0M | $155.0M | $149.0M | $163.0M | $167.0M |
| Other Current Assets | $40.00M | $54.00M | $40.00M | $16.00M | $19.00M | $20.00M | $20.00M | $21.00M |
| **Total Current Assets** | $800.0M | $725.0M | $667.0M | $652.0M | $922.0M | $951.0M | $883.0M | $827.0M |
| Property, Plant & Equipment, Net | $175.0M | $162.0M | $157.0M | $144.0M | $124.0M | $117.0M | $104.0M | $100.0M |
| Goodwill | -- | -- | -- | $2.00M | -- | -- | -- | $2.00M |
| Long-Term Investments | $27.00M | $27.00M | $27.00M | $28.00M | $28.00M | $27.00M | $27.00M | $27.00M |
| Other Non-Current Assets | $27.00M | $24.00M | $26.00M | $27.00M | $27.00M | $44.00M | $39.00M | $39.00M |
| **Total Non-Current Assets** | $532.0M | $508.0M | $530.0M | $549.0M | $494.0M | $501.0M | $492.0M | $489.0M |
| **Total Assets** | $1.33B | $1.23B | $1.20B | $1.20B | $1.42B | $1.45B | $1.38B | $1.32B |
| Accounts Payable | $28.00M | $30.00M | $35.00M | $48.00M | $41.00M | $50.00M | $46.00M | $63.00M |
| Short-Term Debt | $488.0M | $0 | $0 | $29.00M | $18.00M | $18.00M | $18.00M | $18.00M |
| Other Current Liabilities | -- | -- | -- | $0 | $0 | $0 | $3.00M | $11.00M |
| **Total Current Liabilities** | $1.30B | $868.0M | $779.0M | $914.0M | $965.0M | $1.06B | $1.00B | $924.0M |
| Long-Term Debt | $0 | $487.0M | $486.0M | $290.0M | $304.0M | $308.0M | $311.0M | $315.0M |
| Other Non-Current Liabilities | $42.00M | $31.00M | $21.00M | $21.00M | $30.00M | $18.00M | $17.00M | $18.00M |
| **Total Non-Current Liabilities** | $91.00M | $573.0M | $562.0M | $386.0M | $658.0M | $653.0M | $655.0M | $728.0M |
| **Total Liabilities** | $1.39B | $1.44B | $1.34B | $1.30B | $1.62B | $1.71B | $1.66B | $1.65B |
| **Total Debt (incl. Leases)** | $501.0M | $509.0M | $509.0M | $351.0M | $356.0M | $366.0M | $370.0M | $375.0M |
| Common Stock | $0 | $0 | $0 | $62.00M | $62.00M | $62.00M | $62.00M | $62.00M |
| Retained Earnings | -$197.0M | -$334.0M | -$280.0M | -$243.0M | -$346.0M | -$388.0M | -$406.0M | -$443.0M |
| Accumulated Other Comp. Income | -$26.00M | -$28.00M | -$29.00M | -$30.00M | -$32.00M | -$33.00M | -$35.00M | -$36.00M |
| **Total Stockholders' Equity** | -$60.00M | -$208.0M | -$144.0M | -$98.00M | -$207.0M | -$257.0M | -$285.0M | -$337.0M |
| Total Equity | -$60.00M | -$208.0M | -$144.0M | -$98.00M | -$207.0M | -$257.0M | -$285.0M | -$337.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | $210.0M | $7.00M | -$126.0M | -$42.00M | $205.0M |
| Depreciation & Amortization | $10.00M | $16.00M | $15.00M | $16.00M | $15.00M |
| Stock-Based Compensation | $26.00M | $24.00M | $21.00M | $16.00M | $11.00M |
| Change in Receivables | $3.00M | -$1.00M | -$33.00M | -$21.00M | -$25.00M |
| Change in Inventory | $18.00M | -$43.00M | -$6.00M | -$30.00M | -$3.00M |
| **Operating Cash Flow** | -$27.00M | $36.00M | -$300.0M | -$4.00M | $353.0M |
| Capital Expenditure | -$66.00M | -$29.00M | -$8.00M | -$5.00M | -$4.00M |
| **Free Cash Flow** | -$93.00M | $7.00M | -$308.0M | -$9.00M | $349.0M |
| Acquisitions, Net | $0 | $0 | -$129.0M | $0 | $0 |
| **Investing Cash Flow** | -$66.00M | $69.00M | -$95.00M | -$222.0M | -$14.00M |
| Common Stock Issued | $2.00M | $3.00M | $3.00M | $2.00M | -- |
| Share Repurchases | -$11.00M | -$173.0M | -$33.00M | -$90.00M | -$101.0M |
| **Financing Cash Flow** | -$30.00M | -$102.0M | -$64.00M | -$101.0M | -$94.00M |
| **Net Change in Cash** | -$124.0M | $3.00M | -$459.0M | -$327.0M | $244.0M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $137.0M | $122.0M | $89.00M | $102.0M | $42.00M | $18.00M | $47.00M | $21.00M |
| Depreciation & Amortization | $1.00M | $2.00M | $2.00M | $2.00M | $3.00M | $2.00M | $3.00M | $5.00M |
| Stock-Based Compensation | $8.00M | $11.00M | $9.00M | $5.00M | $7.00M | $8.00M | $6.00M | $6.00M |
| Change in Receivables | -$2.00M | $3.00M | -$20.00M | $6.00M | -$18.00M | $4.00M | $11.00M | -$4.00M |
| Change in Inventory | $1.00M | $4.00M | -$1.00M | $2.00M | -$6.00M | $17.00M | $5.00M | -$2.00M |
| **Operating Cash Flow** | $97.00M | $229.0M | -$9.00M | -$221.0M | -$39.00M | $158.0M | $75.00M | -$17.00M |
| Capital Expenditure | -$14.00M | -$7.00M | -$20.00M | -$24.00M | -$20.00M | -$17.00M | -$5.00M | -$16.00M |
| **Free Cash Flow** | $83.00M | $222.0M | -$29.00M | -$245.0M | -$59.00M | $141.0M | $70.00M | -$33.00M |
| **Investing Cash Flow** | -$14.00M | -$8.00M | -$19.00M | -$24.00M | -$20.00M | -$17.00M | -$5.00M | $8.00M |
| Common Stock Issued | $0 | $0 | $0 | $0 | $1.00M | $0 | $1.00M | $0 |
| Share Repurchases | $0 | -$177.0M | -$125.0M | $0 | $0 | $0 | -$11.00M | -$50.00M |
| **Financing Cash Flow** | $0 | -$173.0M | $7.00M | -$5.00M | -$3.00M | -$5.00M | -$17.00M | $40.00M |
| **Net Change in Cash** | $82.00M | $48.00M | -$20.00M | -$252.0M | -$61.00M | $136.0M | $53.00M | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 80.2% | 80.6% | 84.1% | 83.1% | 83.9% |
| **Operating Margin** | 21.1% | 3.2% | -13.9% | -8.5% | 26.9% |
| **Net Profit Margin** | 16.9% | 0.6% | -11.5% | -4.7% | 25.9% |
| Return on Equity (ROE) | -- | -- | -- | -- | 169.4% |
| Return on Assets (ROA) | 17.5% | 0.5% | -7.2% | -2.4% | 11.2% |
| Current Ratio | 0.71x | 0.90x | 0.98x | 1.24x | 1.80x |
| Quick Ratio | 0.55x | 0.71x | 0.88x | 1.12x | 1.68x |
| Debt to Equity | -- | -- | -- | -- | 2.98x |
| **Revenue Growth (YoY)** | +4.3% | +8.7% | +21.3% | +13.9% | -- |
| Gross Profit Growth (YoY) | +3.9% | +4.1% | +22.7% | +12.8% | -- |
| Operating Income Growth (YoY) | +589.5% | -- | -- | -136.2% | -- |
| **Net Income Growth (YoY)** | +2900.0% | -- | -- | -120.5% | -- |
| EPS Growth (YoY) | +3260.0% | -- | -- | -104.3% | -- |
| Operating Cash Flow Growth (YoY) | -175.0% | -- | -- | -101.1% | -- |
| Free Cash Flow Growth (YoY) | -1428.6% | -- | -- | -102.6% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 85.0% | 82.1% | 81.3% | 80.1% | 80.5% | 81.9% | 79.6% | 80.5% |
| **Operating Margin** | 40.6% | 31.6% | 25.8% | 21.1% | 19.2% | 18.7% | 2.5% | 3.2% |
| **Net Profit Margin** | 32.8% | 26.7% | 19.4% | 16.9% | 10.8% | 9.2% | -0.6% | 0.6% |
| Return on Assets (ROA) | 33.8% | 28.8% | 21.0% | 17.4% | 9.0% | 7.4% | -0.5% | 0.5% |
| Current Ratio | 0.61x | 0.84x | 0.86x | 0.71x | 0.96x | 0.90x | 0.88x | 0.90x |
| Quick Ratio | 0.50x | 0.66x | 0.66x | 0.55x | 0.79x | 0.76x | 0.72x | 0.71x |
| **Revenue Growth (YoY)** | +13.4% | +13.6% | +19.2% | +19.7% | +2.3% | +1.0% | -6.3% | -- |
| Gross Profit Growth (YoY) | +32.6% | +17.6% | +25.3% | +16.8% | -4.6% | +13.6% | -10.2% | -- |
| Operating Income Growth (YoY) | +318.6% | +122.2% | +107.6% | +76.1% | +22.9% | -- | -12.0% | -- |
| **Net Income Growth (YoY)** | +226.2% | +577.8% | +89.4% | +385.7% | +90.9% | -- | -23.0% | -- |
| EPS Growth (YoY) | +241.2% | +580.0% | +86.8% | -- | +112.5% | -- | -15.6% | -- |
| Operating Cash Flow Growth (YoY) | -- | +44.9% | -112.0% | -- | -2050.0% | +79.5% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | +57.4% | -141.4% | -- | -- | +67.9% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
